Taiwan FDA registration a3d0736f70e4203a289a9aa055c66824
Ebiel Epstein-Barr virus early antigen IgA antibody test group
TW: 艾必爾 EB病毒早期抗原IgA抗體測試組
Taiwan·IBL GMBH GESELLSCHAFT FÜR IMMUNOCHEMIE UND IMMUNOBIOLOGIE MBH·Registered Dec 09, 2005 – Dec 09, 2010CancelledRegistration details
- Analysis ID
- a3d0736f70e4203a289a9aa055c66824
- Customs Code
- DHA00601536403
Company information
- Manufacturer Country
- Germany
- Authorized Representative
- Dachen Biotechnology Co., Ltd
Product details
- Intended Use
- Enzyme immunoassays were used to quantitatively and quantitatively detect human serum and blood water.
- Product Type (Level 1)
- C Immunology and microbiology
- Product Type (Level 2)
- C.3235 EB病毒血清試劑
- Import Information
- import
Dates and status
- Registration Date
- Dec 09, 2005
- Expiry Date
- Dec 09, 2010
- Cancellation Date
- Nov 06, 2012
Cancellation information
- Status
- Logged out
- Reason
- 許可證已逾有效期
About this record
Access comprehensive regulatory information for Ebiel Epstein-Barr virus early antigen IgA antibody test group in Taiwan's medical device market through Pure Global AI's free database. is registered under number a3d0736f70e4203a289a9aa055c66824 and manufactured by IBL GMBH GESELLSCHAFT FÜR IMMUNOCHEMIE UND IMMUNOBIOLOGIE MBH. The authorized representative in Taiwan is Dachen Biotechnology Co., Ltd.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices